Biohit Oyj Class B (EUR)
BIOBV
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range2.19 | 2.22
52-Wk Range- | -
Last Close2.19
Mkt Cap (m)32.95
Dividend yield-
ISINFI0009005482
Volume21,478.00
Exchange VenueHEL

Company Profile

Biohit Oyj is a biotechnology company. It manufactures products that bind acetaldehyde, diagnostic products and systems for diagnostic analysis for the use of research institutions, health care and industry.

Key Information
Price/Earning-
Price/Book3.43
Price/Sales4.09
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Prospectus
en 07/09/2018
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.biohithealthcare.com

Financials

Income Statement
EUR201520162017201820192020
Revenue (m)6.058.208.989.9310.05-
Operating Income (m)-3.56-3.17-1.63-1.96-1.41-
Net Income (m)-2.92-3.306.14-2.14-1.42-
Basic EPS-0.20-0.220.42-0.14-0.09-
Avg. Diluted Shares Outstanding (m)14.7015.0514.9415.0215.01-
Balance Sheet
EUR201520162017201820192020
Current Assets (m)8.8810.5911.3512.2313.21-
Non Current Assets (m)2.852.407.545.664.16-
Total Assets (m)11.7312.9918.9017.8917.37-
Current Liabilities (m)1.241.821.281.572.38-
Total Liabilities (m)------
Total Equity (m)10.3110.7517.2415.8914.58-
Cash Flows
EUR201520162017201820192020
Operating Cash Flows (m)-3.15-2.46-0.94-0.090.08-
Capital Expenditure (m)-0.22-0.09-0.17-0.02-0.05-
Figures are quoted in EUR unless stated otherwise
0.02 (0.91%)
2.21
Last Price